Newsroom

Newsroom

Deep phenotyping and spatial interrogation of the NSCLC tumor microenvironment using the fully validated Next Generation MultiOmyx™ Platform

Literature
Read More

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Press Release
Read More

NEO | AML Express™ whitepaper

Literature
Read More

NeoGenomics Reports Third Quarter 2024 Results

Press Release
Read More

A multiomics approach using transcriptomic and spatial analysis to identify predictive immune biomarkers of response and toxicity following chemotherapy in head & neck cancers

Literature
Read More

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

Press Release
Read More

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

Press Release
Read More

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients